This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aguilar OA, Qualls AE, Gonzalez-Hinojosa MDR et al (2024) MICB genomic variant is associated with NKG2D-mediated acute lung injury and death. Am J Respir Crit Care Med 209:70–82. https://doi.org/10.1164/rccm.202303-0472OCAguilarOAQuallsAEGonzalez-HinojosaMDR2024MICB genomic variant is associated with NKG2D-mediated acute lung injury and death2097082https://doi.org/10.1164/rccm.202303-0472OCSearch in Google Scholar
Baek IC, Shin DH, Choi EJ et al (2018) Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients. Blood Cancer J 8:58. https://doi.org/10.1038/s41408-018-0092-5BaekICShinDHChoiEJ2018Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients858https://doi.org/10.1038/s41408-018-0092-5Search in Google Scholar
Blunt MD, Khakoo SI (2023) Harnessing natural killer cell effector function against cancer. Immunother Adv 4:ltad031. https://doi.org/10.1093/immadv/ltad031BluntMDKhakooSI2023Harnessing natural killer cell effector function against cancer4ltad031https://doi.org/10.1093/immadv/ltad031Search in Google Scholar
Bogunia-Kubik K, Łacina P (2021) Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. Int J Immunogenet 48:157–171. https://doi.org/10.1111/iji.12523Bogunia-KubikKŁacinaP2021Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells48157171https://doi.org/10.1111/iji.12523Search in Google Scholar
Boutet P, Agüera-González S, Atkinson S et al (2009) Cutting edge: The metalloproteinase ADAM17/TNF-α-converting enzyme regulates proteolytic shedding of the MHC Class I-related chain B protein. J Immunol 182:49–53. https://doi.org/10.4049/jimmunol.182.1.49BoutetPAgüera-GonzálezSAtkinsonS2009Cutting edge: The metalloproteinase ADAM17/TNF-α-converting enzyme regulates proteolytic shedding of the MHC Class I-related chain B protein1824953https://doi.org/10.4049/jimmunol.182.1.49Search in Google Scholar
Carapito R, Aouadi I, Pichot A et al (2020) Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status. Bone Marrow Transplant 55:1367–1378. https://doi.org/10.1038/s41409-020-0886-5CarapitoRAouadiIPichotA2020Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status5513671378https://doi.org/10.1038/s41409-020-0886-5Search in Google Scholar
Chitadze G, Bhat J, Lettau M et al (2013) Generation of soluble NKG2D ligands: Proteolytic cleavage, exosome secretion and functional implications. Scand J Immunol 78:120–129. https://doi.org/10.1111/sji.12072ChitadzeGBhatJLettauM2013Generation of soluble NKG2D ligands: Proteolytic cleavage, exosome secretion and functional implications78120129https://doi.org/10.1111/sji.12072Search in Google Scholar
Doubrovina ES, Doubrovin MM, Vider E et al (2003) Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 171:6891–6899. https://doi.org/10.4049/jimmunol.171.12.6891DoubrovinaESDoubrovinMMViderE2003Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma17168916899https://doi.org/10.4049/jimmunol.171.12.6891Search in Google Scholar
Eberhardt KA, Jung V, Knops E et al (2023) CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality. Bone Marrow Transplant 58:639–646. https://doi.org/10.1038/s41409-023-01944-2EberhardtKAJungVKnopsE2023CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality58639646https://doi.org/10.1038/s41409-023-01944-2Search in Google Scholar
Faridah IN, Dania H, Maliza R et al (2023) Genetic association studies of MICB and PLCE1 with severity of dengue in Indonesian and Taiwanese populations. Diagnostics 13:3365. https://doi.org/10.3390/diagnostics13213365FaridahINDaniaHMalizaR2023Genetic association studies of MICB and PLCE1 with severity of dengue in Indonesian and Taiwanese populations133365https://doi.org/10.3390/diagnostics13213365Search in Google Scholar
Farzad F, Yaghoubi N, Jabbari-Azad F et al (2022) Prognostic value of serum MICA levels as a marker of severity in COVID-19 patients. Immunol Invest 51:1856–1866. https://doi.org/10.1080/08820139.2022.2069035FarzadFYaghoubiNJabbari-AzadF2022Prognostic value of serum MICA levels as a marker of severity in COVID-19 patients5118561866https://doi.org/10.1080/08820139.2022.2069035Search in Google Scholar
Fuerst D, Neuchel C, Niederwieser D et al (2016) Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation. Blood 128:3169–3176. https://doi.org/10.1182/blood-2016-05-716357FuerstDNeuchelCNiederwieserD2016Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation12831693176https://doi.org/10.1182/blood-2016-05-716357Search in Google Scholar
González-Cruz C, Repiso T, Ferrándiz-Pulido C et al (2023) Risk factors and clinical characteristics of acute and chronic cutaneous graft-versus-host disease in pediatric patients undergoing hematopoietic stem cell transplantation. Pediatr Dermatol 40:1077–1080. https://doi.org/10.1111/pde.15447González-CruzCRepisoTFerrándiz-PulidoC2023Risk factors and clinical characteristics of acute and chronic cutaneous graft-versus-host disease in pediatric patients undergoing hematopoietic stem cell transplantation4010771080https://doi.org/10.1111/pde.15447Search in Google Scholar
Goulding J, Yeh WI, Hancock B et al (2023) A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors. Med 4:457–477.e8. https://doi.org/10.1016/j.medj.2023.04.004GouldingJYehWIHancockB2023A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors4457477.e8https://doi.org/10.1016/j.medj.2023.04.004Search in Google Scholar
Groh V, Wu J, Yee C et al (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734–738. https://doi.org/10.1038/nature01112GrohVWuJYeeC2002Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation419734738https://doi.org/10.1038/nature01112Search in Google Scholar
Holdenrieder S, Stieber P, Peterfi A et al (2006a) Soluble MICA in malignant diseases. Int J Cancer 118:684–687. https://doi.org/10.1002/ijc.21382HoldenriederSStieberPPeterfiA2006aSoluble MICA in malignant diseases118684687https://doi.org/10.1002/ijc.21382Search in Google Scholar
Holdenrieder S, Stieber P, Peterfi A et al (2006b) Soluble MICB in malignant diseases: Analysis of diagnostic significance and correlation with soluble MICA. Cancer Immunol Immunother 55:1584–1589. https://doi.org/10.1007/s00262-006-0167-1HoldenriederSStieberPPeterfiA2006bSoluble MICB in malignant diseases: Analysis of diagnostic significance and correlation with soluble MICA5515841589https://doi.org/10.1007/s00262-006-0167-1Search in Google Scholar
Holtick U, Quignot N, Kapso-Kapnang R et al (2024) Clinical and economic burden associated with acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in Germany. Transplant Proc 56:191–200. https://doi.org/10.1016/j.transproceed.2023.11.032HoltickUQuignotNKapso-KapnangR2024Clinical and economic burden associated with acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in Germany56191200https://doi.org/10.1016/j.transproceed.2023.11.032Search in Google Scholar
Isernhagen A, Malzahn D, Viktorova E et al (2015) The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation. EMBO Mol Med 7:1480–1502. https://doi.org/10.15252/emmm.201505246IsernhagenAMalzahnDViktorovaE2015The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation714801502https://doi.org/10.15252/emmm.201505246Search in Google Scholar
Ivanova M, Al Hadra B, Yordanov S et al (2021) Associations of high-resolution-typing-defined MICA and MICB polymorphisms, and the levels of soluble MICA and MICB with oral squamous cell carcinoma in Bulgarian patients. J Oral Pathol Med 50:758–765. https://doi.org/10.1111/jop.13185IvanovaMAl HadraBYordanovS2021Associations of high-resolution-typing-defined MICA and MICB polymorphisms, and the levels of soluble MICA and MICB with oral squamous cell carcinoma in Bulgarian patients50758765https://doi.org/10.1111/jop.13185Search in Google Scholar
Kaidun P, Holzmayer SJ, Greiner SM et al (2023) Targeting NKG2DL with bispecific NKG2D-CD16 and NKG2D-CD3 fusion proteins on triple-negative breast cancer. Int J Mol Sci 24:13156. https://doi.org/10.3390/ijms241713156KaidunPHolzmayerSJGreinerSM2023Targeting NKG2DL with bispecific NKG2D-CD16 and NKG2D-CD3 fusion proteins on triple-negative breast cancer2413156https://doi.org/10.3390/ijms241713156Search in Google Scholar
Kshersagar J, Damle MN, Bedge P et al (2022) Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer. Breast Dis 41:471–480. https://doi.org/10.3233/BD-220023KshersagarJDamleMNBedgeP2022Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer41471480https://doi.org/10.3233/BD-220023Search in Google Scholar
Machuldova A, Houdova L, Kratochvilova K et al (2021) Single-nucleotide polymorphisms in MICA and MICB genes could play a role in the outcome in AML patients after HSCT. J Clin Med 10:4636. https://doi.org/10.3390/jcm10204636MachuldovaAHoudovaLKratochvilovaK2021Single-nucleotide polymorphisms in MICA and MICB genes could play a role in the outcome in AML patients after HSCT104636https://doi.org/10.3390/jcm10204636Search in Google Scholar
Nagai K, Tawara T, Usui J et al (2022) Levels of soluble NKG2D ligands and cancer history in patients starting hemodialysis. Front Nephrol 2:875207. https://doi.org/10.3389/fneph.2022.875207NagaiKTawaraTUsuiJ2022Levels of soluble NKG2D ligands and cancer history in patients starting hemodialysis2875207https://doi.org/10.3389/fneph.2022.875207Search in Google Scholar
Nuckel H, Switala M, Sellmann L et al (2010) The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 24:1152–1159. https://doi.org/10.1038/leu.2010.74NuckelHSwitalaMSellmannL2010The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia2411521159https://doi.org/10.1038/leu.2010.74Search in Google Scholar
Onyeaghala G, Nelson HH, Thyagarajan B et al (2017) Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study. Mol Carcinog 56:2158–2164. https://doi.org/10.1002/mc.22667OnyeaghalaGNelsonHHThyagarajanB2017Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study5621582164https://doi.org/10.1002/mc.22667Search in Google Scholar
Ouni N, Ben Chaaben A, Ayari F et al (2020) MICA-129 Met/Val polymorphism could be a genetic biomarker for familial breast cancer in the Tunisian population. Int J Immunogenet 47:406–413. https://doi.org/10.1111/iji.12480OuniNBen ChaabenAAyariF2020MICA-129 Met/Val polymorphism could be a genetic biomarker for familial breast cancer in the Tunisian population47406413https://doi.org/10.1111/iji.12480Search in Google Scholar
Ouni N, Ben Chaaben A, Kablouti G et al (2017) MICA-129Met/Val polymorphism is associated with early-onset breast cancer risk. Immunol Invest 46:603–614. https://doi.org/10.1080/08820139.2017.1336175OuniNBen ChaabenAKabloutiG2017MICA-129Met/Val polymorphism is associated with early-onset breast cancer risk46603614https://doi.org/10.1080/08820139.2017.1336175Search in Google Scholar
Parmar S, Del Lima M, Zou Y et al (2009) Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 114:2884–2887. https://doi.org/10.1182/blood-2009-05-223172ParmarSDel LimaMZouY2009Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease11428842887https://doi.org/10.1182/blood-2009-05-223172Search in Google Scholar
Passweg JR, Baldomero H, Ciceri F et al (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT Activity Survey. Bone Marrow Transplant 58:647–658. https://doi.org/10.1038/s41409-023-01943-3PasswegJRBaldomeroHCiceriF2023Hematopoietic cell transplantation and cellular therapies in Europe 202158647658https://doi.org/10.1038/s41409-023-01943-3Search in Google Scholar
Patil S, Schwarer T (2009) Natural killer cells − new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation. Intern Med J 39:639–647. https://doi.org/10.1111/j.1445-5994.2009.02024.xPatilSSchwarerT2009Natural killer cells − new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation39639647https://doi.org/10.1111/j.1445-5994.2009.02024.xSearch in Google Scholar
Petersdorf EW, McKallor C, Malkki M et al (2023) Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation. Blood Adv 7:2888–2896. https://doi.org/10.1182/bloodadvances.2022008922PetersdorfEWMcKallorCMalkkiM2023Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation728882896https://doi.org/10.1182/bloodadvances.2022008922Search in Google Scholar
Peterson EE, Barry KC (2021) The natural killer-dendritic cell immune axis in anti-cancer immunity and immunotherapy. Front Immunol 11:621254. https://doi.org/10.3389/fimmu.2020.621254PetersonEEBarryKC2021The natural killer-dendritic cell immune axis in anti-cancer immunity and immunotherapy11621254https://doi.org/10.3389/fimmu.2020.621254Search in Google Scholar
Prokopeva AE, Emene CC, Gomzikova MO (2023) Antitumor immunity: Role of NK cells and extracellular vesicles in cancer immunotherapy. Curr Issues Mol Biol 46:140–152. https://doi.org/10.3390/cimb46010011ProkopevaAEEmeneCCGomzikovaMO2023Antitumor immunity: Role of NK cells and extracellular vesicles in cancer immunotherapy46140152https://doi.org/10.3390/cimb46010011Search in Google Scholar
Raffaghello L, Prigione I, Airoldi I et al (2004) Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia 6:558–568. https://doi.org/10.1593/neo.04316RaffaghelloLPrigioneIAiroldiI2004Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma6558568https://doi.org/10.1593/neo.04316Search in Google Scholar
Ribeiro CH, Kramm K, Gálvez-Jirón F et al (2016) Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients. Oncol Rep 35:1309–1317. https://doi.org/10.3892/or.2015.4510RibeiroCHKrammKGálvez-JirónF2016Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients3513091317https://doi.org/10.3892/or.2015.4510Search in Google Scholar
Salih HR, Goehlsdorf D, Steinle A (2006) Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients. Hum Immunol 67:188–195. https://doi.org/10.1016/j.humimm.2006.02.008SalihHRGoehlsdorfDSteinleA2006Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients67188195https://doi.org/10.1016/j.humimm.2006.02.008Search in Google Scholar
Sánchez-Cerrillo I, Calzada-Fraile D, Triguero-Martínez A et al (2023) MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity. EMBO J 42:e113714. https://doi.org/10.15252/embj.2023113714Sánchez-CerrilloICalzada-FraileDTriguero-MartínezA2023MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity42e113714https://doi.org/10.15252/embj.2023113714Search in Google Scholar
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K (2021) NKG2D natural killer cell receptor-a short description and potential clinical applications. Cells 10:1420. https://doi.org/10.3390/cells10061420SiemaszkoJMarzec-PrzyszlakABogunia-KubikK2021NKG2D natural killer cell receptor-a short description and potential clinical applications101420https://doi.org/10.3390/cells10061420Search in Google Scholar
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K (2023) Activating NKG2C receptor: Functional characteristics and current strategies in clinical applications. Arch Immunol Ther Exp 71:9. https://doi.org/10.1007/s00005-023-00674-zSiemaszkoJMarzec-PrzyszlakABogunia-KubikK2023Activating NKG2C receptor: Functional characteristics and current strategies in clinical applications719https://doi.org/10.1007/s00005-023-00674-zSearch in Google Scholar
Spreu J, Stehle T, Steinle A (2006) Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their α2 domains. J Immunol 177:3143–3149. https://doi.org/10.4049/jimmunol.177.5.3143SpreuJStehleTSteinleA2006Human cytomegalovirus-encoded UL16 discriminates MIC molecules by their α2 domains17731433149https://doi.org/10.4049/jimmunol.177.5.3143Search in Google Scholar
Sulaiman NY, Anuar NA, Arshad N et al (2024) CMV infection post allogeneic hematopoietic stem cell transplantation in a resource limited country. Indian J Hematol Blood Transfus 40:97–102. https://doi.org/10.1007/s12288-023-01655-0SulaimanNYAnuarNAArshadN2024CMV infection post allogeneic hematopoietic stem cell transplantation in a resource limited country4097102https://doi.org/10.1007/s12288-023-01655-0Search in Google Scholar
Suresh PK (2016) Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies. J Cancer Res Ther 12:1224–1233. https://doi.org/10.4103/0973-1482.176169SureshPK2016Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies1212241233https://doi.org/10.4103/0973-1482.176169Search in Google Scholar
Vela-Ojeda J, Perez-Retiguin FDC, Olivas-Bejarano AC et al (2021) Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma. Leuk Lymphoma 62:801–809. https://doi.org/10.1080/10428194.2020.1852473Vela-OjedaJPerez-RetiguinFDCOlivas-BejaranoAC2021Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma62801809https://doi.org/10.1080/10428194.2020.1852473Search in Google Scholar
Wang CM, Tan KP, Jan Wu YJ et al (2021) MICA*019 allele and soluble MICA as biomarkers for ankylosing spondylitis in Taiwanese. J Pers Med 11:564. https://doi.org/10.3390/jpm11060564WangCMTanKPJan WuYJ2021MICA*019 allele and soluble MICA as biomarkers for ankylosing spondylitis in Taiwanese11564https://doi.org/10.3390/jpm11060564Search in Google Scholar
Wang LP, Niu H, Xia YF et al (2015) Prognostic significance of serum sMICA levels in non-small cell lung cancer. Eur Rev Med Pharmacol Sci 19:2226–2230WangLPNiuHXiaYF2015Prognostic significance of serum sMICA levels in non-small cell lung cancer1922262230Search in Google Scholar
Wang Y, Li S, Chen C et al (2019) MICB*002 and MICB*014 protect against rheumatoid arthritis, whereas MICA*009 and MICA*A6 are associated with rheumatoid arthritis in a Hainan Han Chinese population. Int J Rheum Dis 22:90–95. https://doi.org/10.1111/1756-185X.13302WangYLiSChenC2019MICB*002 and MICB*014 protect against rheumatoid arthritis, whereas MICA*009 and MICA*A6 are associated with rheumatoid arthritis in a Hainan Han Chinese population229095https://doi.org/10.1111/1756-185X.13302Search in Google Scholar
Wu JD, Higgins LM, Steinle A et al (2004) Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 114:560–568. https://doi.org/10.1172/JCI22206WuJDHigginsLMSteinleA2004Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer114560568https://doi.org/10.1172/JCI22206Search in Google Scholar
Xu Z, Taylor JA (2009) SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37(Web Server issue):W600-5. https://doi.org/10.1093/nar/gkp290XuZTaylorJA2009SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies37(Web Server issue):W600-5https://doi.org/10.1093/nar/gkp290Search in Google Scholar
Yu P, Zhu Q, Chen C et al (2017) Association between major histocompatibility complex Class I chain-related gene polymorphisms and susceptibility of systemic lupus erythematosus. Am J Med Sci 354:430–435. https://doi.org/10.1016/j.amjms.2017.06.003YuPZhuQChenC2017Association between major histocompatibility complex Class I chain-related gene polymorphisms and susceptibility of systemic lupus erythematosus354430435https://doi.org/10.1016/j.amjms.2017.06.003Search in Google Scholar
Zingoni A, Vulpis E, Cecere F et al (2018) MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma. Front Immunol 9:926. https://doi.org/10.3389/fimmu.2018.00926ZingoniAVulpisECecereF2018MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma9926https://doi.org/10.3389/fimmu.2018.00926Search in Google Scholar
Zocchi MR, Camodeca C, Nuti E et al (2015) ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing. Oncoimmunology 5:e1123367. https://doi.org/10.1080/2162402X.2015.1123367ZocchiMRCamodecaCNutiE2015ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing5e1123367https://doi.org/10.1080/2162402X.2015.1123367Search in Google Scholar